The Cognitive & Brain Health Stack: Cerebrolysin + Semax + Selank

Cognitive decline is not something that waits until retirement age to announce itself. By the time a man notices he is forgetting names, losing focus in meetings, struggling to learn new skills, or feeling mentally foggy by 2 PM, the underlying neurological changes have been developing for years. BDNF (brain-derived neurotrophic factor) production declines with age. Synaptic connections weaken. Neuroinflammation increases. The brain's capacity for neuroplasticity, the ability to form new connections and adapt to new information, deteriorates gradually and relentlessly.

This stack addresses cognitive decline and brain health from three complementary angles: Cerebrolysin provides broad neuroprotective and neurotrophic support through a complex mixture of brain-derived peptides. Semax enhances BDNF production, dopaminergic signaling, and cognitive processing speed. Selank provides anxiolytic support and GABA modulation without the cognitive impairment of traditional anti-anxiety medications. Together, they create a comprehensive neuroprotective and neuroenhancing protocol.

Unlike most nootropics on the market (caffeine pills, herbal extracts, and synthetic stimulants), these three compounds have actual clinical history. Cerebrolysin has been used clinically for over 40 years in Europe and Asia. Semax and Selank are approved pharmaceutical drugs in Russia. This does not make them risk-free, but it means the evidence base extends well beyond theoretical mechanisms and animal studies.

Cerebrolysin: The Neurotrophic Foundation

Cerebrolysin is a multi-component peptide preparation derived from porcine (pig) brain tissue through a standardized biotechnological process. It consists of approximately 25% low-molecular-weight neuropeptides and 75% free amino acids. The peptide fraction contains fragments that mimic the activity of naturally occurring neurotrophic factors including BDNF, CNTF (ciliary neurotrophic factor), GDNF (glial cell line-derived neurotrophic factor), and NGF (nerve growth factor).

What distinguishes Cerebrolysin from single-compound nootropics is this multi-target approach. The brain does not run on a single neurotrophic factor. It relies on a complex orchestra of signaling molecules, and Cerebrolysin provides a broad spectrum of neuropeptide support that more closely mimics the brain's natural signaling environment than any single synthetic compound can achieve.

Clinical Evidence

Cerebrolysin has one of the most extensive clinical research databases of any nootropic compound, with over 200 clinical studies published:

• Stroke recovery: Multiple randomized controlled trials have demonstrated improved neurological outcomes in stroke patients receiving Cerebrolysin within 72 hours of ischemic stroke. The CASTA study (n=1,070) showed improvement in neurological scores, though the primary endpoint did not reach statistical significance in the full population. The E-COMPASS study with combined alteplase showed more promising results
• Traumatic brain injury: Clinical studies have shown improved cognitive recovery and reduced disability in TBI patients treated with Cerebrolysin, with the CAPTAIN trial demonstrating significant benefits in moderate-to-severe TBI
• Alzheimer's disease: Multiple studies have demonstrated improvements in cognitive function scores (ADAS-cog) in mild-to-moderate Alzheimer's patients, with effects that persist for months after treatment cessation, suggesting structural neural changes rather than just symptomatic improvement
• Cognitive enhancement in healthy individuals: Smaller studies and clinical observations suggest improvements in attention, memory, and processing speed in healthy adults, though the evidence base here is less robust than for pathological conditions

Protocol Framework

Cerebrolysin is unique in this stack because it is administered via intramuscular injection rather than subcutaneous or intranasal. The clinical dosing from the research literature:

• Dose: 5-10mL per day via intramuscular injection for cognitive enhancement in otherwise healthy men. Clinical protocols for neurological conditions use up to 30mL intravenously, but this is not applicable to optimization use
• Cycle length: 10-20 treatment days per cycle (this is the approach used in most clinical studies)
• Frequency: 2-4 cycles per year depending on goals
• Injection method: Intramuscular, typically gluteal or deltoid. The larger volume (5-10mL) makes subcutaneous administration impractical

Semax: The Cognitive Amplifier

Semax is a synthetic heptapeptide (seven amino acids) based on the 4-10 fragment of ACTH (adrenocorticotropic hormone). It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and has been approved as a pharmaceutical drug in Russia since 2011 for the treatment of stroke, transient ischemic attack, cognitive disorders of various origins, peptic ulcer disease, and optic nerve disease.

Unlike ACTH itself, Semax does not stimulate the adrenal glands or cortisol production. The 4-10 fragment retains the neurotropic (brain-supporting) properties of ACTH while lacking the steroidogenic (hormone-stimulating) properties. This is a critical distinction because it means Semax provides cognitive enhancement without the HPA axis disruption that would make it unsustainable for long-term use.

Mechanisms of Action

• BDNF upregulation: Semax significantly increases BDNF expression in the hippocampus and cortex, the brain regions most critical for memory formation and executive function. This is its most important mechanism for cognitive enhancement
• Dopaminergic enhancement: Semax modulates dopamine and serotonin metabolism in the brain, enhancing the neurotransmitter signaling responsible for focus, motivation, reward processing, and mood. Users frequently describe this as a “clean focus” without the jitteriness of stimulants
• Neuroprotection: The peptide reduces oxidative stress in neural tissue and protects neurons from excitotoxicity (damage from excessive neural stimulation), which is relevant for both acute brain injury and chronic neurodegeneration
• Enhanced neuroplasticity: By increasing BDNF and modulating synaptic signaling, Semax improves the brain's ability to form new connections, which translates to improved learning, adaptation, and cognitive flexibility
• Improved cerebral blood flow: Semax has been shown to improve blood circulation in the brain, ensuring adequate oxygen and nutrient delivery to neural tissue

Administration

Semax is most commonly administered as a nasal spray, which provides direct access to the brain through the nasal mucosa and olfactory pathways, bypassing the blood-brain barrier. This makes administration simple and non-invasive:

• Dose: 200-600mcg per day in divided doses (100-200mcg per nostril, 1-3 times daily)
• Administration: Intranasal spray, 1-2 sprays per nostril per dose
• Timing: Morning and early afternoon dosing is preferred, as the dopaminergic effects can interfere with sleep if taken late
• Duration: Cycles of 10-20 days, with at least equal time off between cycles. Some practitioners recommend ongoing low-dose use (200mcg/day) with periodic higher-dose cycles
• Variants: N-Acetyl Semax (NASA) and N-Acetyl Semax Amidate (NASA Amidate) are modified versions with potentially enhanced potency and duration of action

Selank: The Anxiolytic Stabilizer

Selank is a synthetic analog of tuftsin, a naturally occurring immunomodulatory peptide (Thr-Lys-Pro-Arg) that is part of the IgG immunoglobulin molecule. Developed at the same Russian institute as Semax, Selank was designed to retain tuftsin's immune-modulatory properties while adding anxiolytic and nootropic effects. It was approved as a pharmaceutical drug in Russia in 2009.

Selank occupies a unique space in this stack because its primary role is anxiolytic (anxiety-reducing) rather than purely cognitive-enhancing. This is not a weakness; it is strategic. Anxiety, stress, and emotional dysregulation are among the biggest destroyers of cognitive performance. A man who is sharp on paper but crippled by anxiety, racing thoughts, or an inability to manage stress is not optimized. Selank addresses this directly, without the sedation, cognitive blunting, or addiction risk of benzodiazepines.

Mechanisms of Action

• GABA modulation: Selank influences GABA receptor function, enhancing the brain's primary inhibitory neurotransmitter system. Unlike benzodiazepines (which directly activate GABA-A receptors and cause sedation and dependence), Selank modulates the system more gently, producing anxiolysis without sedation or cognitive impairment
• Serotonin metabolism: Selank affects the metabolism of serotonin and its metabolite 5-HIAA, influencing mood regulation and emotional stability
• Enkephalin stability: The peptide inhibits the enzymes that degrade enkephalins, the brain's natural “calming” peptides. This extends the duration of the body's own anxiety-buffering system
• Gene expression: Research has shown that Selank influences the expression of 36 genes related to GABA neurotransmission, with effects persisting beyond the active life of the peptide, suggesting structural changes in the brain's anxiety-processing circuitry
• Immune modulation: Selank retains tuftsin's immune-regulatory properties, influencing cytokine balance and supporting immune function. This is a unique secondary benefit not found in traditional anxiolytics

Administration

• Dose: 200-600mcg per day in divided doses, intranasal
• Administration: Nasal spray, same as Semax. Can be administered in the same session as Semax (opposite nostrils or same nostril with a brief pause)
• Timing: Can be used throughout the day including evening. Unlike Semax, Selank does not interfere with sleep and some users report improved sleep quality when using Selank in the evening
• Duration: 14-21 day cycles, though some practitioners use Selank for longer periods at lower doses for sustained anxiolytic support

Stack Synergy: How the Three Work Together

The architecture of this stack is intentional. Each compound addresses a different layer of cognitive function:

• Cerebrolysin provides the foundation: Broad neurotrophic support, neural repair, synaptic maintenance, and long-term neuroprotection. Think of it as the infrastructure maintenance crew for your neural networks
• Semax provides the amplification: Targeted BDNF upregulation, dopaminergic enhancement, and acute cognitive performance improvement. This is the performance upgrade layer
• Selank provides the stabilization: Anxiety reduction, emotional regulation, and GABA balance that prevents the “wired but tired” pattern that undermines long-term cognitive function. This is the stability layer that allows sustainable performance

Without Cerebrolysin, you get acute cognitive enhancement without the underlying neural repair and maintenance. Without Semax, you get neuroprotection without the acute performance uplift. Without Selank, you get cognitive enhancement that may come with anxiety, overstimulation, or emotional instability, particularly in men who are already predisposed to anxiety or operating under high chronic stress.

Complete Protocol Framework

Phase 1: Cerebrolysin Cycle (Days 1-20)

• Cerebrolysin 5-10mL IM injection daily
• Semax 300-600mcg intranasal daily (morning and early afternoon)
• Selank 300-600mcg intranasal daily (morning and/or evening)

Phase 2: Maintenance Between Cerebrolysin Cycles

• Semax 200-400mcg intranasal daily (continue for up to 30 days, then cycle off for equal time)
• Selank 200-400mcg intranasal daily (can be continued for longer periods at lower doses)
• Resume Cerebrolysin cycle every 3-4 months

Supporting Factors for Brain Health

Peptides work within the context of your overall brain health. These factors significantly influence how well this stack works:

• Sleep (7-8+ hours): Sleep is when the brain consolidates memories, clears metabolic waste through the glymphatic system, and performs critical maintenance. No peptide can compensate for chronic sleep deprivation. If you are sleeping less than 7 hours, fixing this will do more for your cognition than any compound
• Exercise: Regular aerobic exercise is one of the most potent natural BDNF stimulators known. Combining exercise with BDNF-enhancing peptides creates a multiplicative effect on neuroplasticity. Zone 2 cardio (moderate intensity, conversational pace) for 150+ minutes per week is the evidence-based minimum
• Omega-3 fatty acids: DHA is a critical structural component of neuronal cell membranes. Supplementing with 2-3g of combined EPA/DHA daily supports the membrane integrity that these peptides are working to enhance
• Stress management: Chronic stress elevates cortisol, which directly suppresses BDNF production, impairs hippocampal function, and accelerates brain aging. Selank helps, but active stress management (meditation, breathwork, time in nature) is important
• Cognitive engagement: The brain operates on a “use it or lose it” principle. The neuroplasticity enhancements from this stack produce the most benefit when combined with active cognitive engagement: learning new skills, reading complex material, problem-solving, and engaging in challenging mental activities

Risks and Considerations

• Cerebrolysin: As a porcine-derived biological product, allergic reactions are possible (though rare). The IM injection volume is large and requires proper technique. Some users report headache or dizziness during the initial days. Contraindicated in epilepsy due to potential effects on seizure threshold. Quality and sourcing are critical, as counterfeiting of Cerebrolysin is unfortunately common
• Semax: Generally very well-tolerated. Some users report mild nasal irritation, headache, or overstimulation at higher doses. The N-Acetyl variants (NASA, NASA Amidate) are more potent and may produce stronger stimulatory effects
• Selank: Well-tolerated with minimal reported side effects. Mild nasal irritation and occasional fatigue are the most common reports. May interact with other GABAergic compounds (benzodiazepines, alcohol) by enhancing their effects

The Bottom Line

The cognitive and brain health stack is built for men who understand that their brain is their most valuable asset and that protecting it requires the same intentional effort as maintaining physical health. Cerebrolysin provides the broad neurotrophic support and neural repair that the aging brain needs. Semax delivers targeted BDNF enhancement and dopaminergic cognitive amplification. Selank provides the anxiolytic stability that allows the cognitive enhancements to express themselves without being undermined by stress and anxiety.

These are not magic pills for instant genius. They are tools that optimize the biological environment in which your brain operates. Combined with adequate sleep, regular exercise, proper nutrition, ongoing cognitive engagement, and stress management, they create the most comprehensive neurological optimization protocol currently available in the peptide space.

For more on the fundamentals of how peptides work, see our Peptides Explained guide. For preparation and administration details, see the Reconstitution Guide and Injection Guides. And if you are new to the concept of hormone optimization, start with Hormones 101 to build the foundational understanding that makes this stack make sense.